Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
As people with HIV live longer, cardiovascular disease has become a leading cause of morbidity and mortality.
Updated guidance is based on findings from the REPRIEVE trial, which showed pitavastatin reduced the risk of cardiovascular events by 35%.
Statins reduce low-density lipoprotein (LDL) cholesterol and also have anti-inflammatory properties.
REPRIEVE trial finds pitavastatin reduced the risk for heart attack, stroke and other major cardiovascular events by 35%.
Large trial finds that pitavastatin lowered the risk for major cardiovascular events by 35%.
People starting on integrase inhibitors were no more likely to have heart attacks, strokes or cardiovascular procedures.
HIV-positive heart transplant recipient (and cancer survivor) Miriam Nieves meets the family of the HIV-positive donor, Brittany Newton.
People with both HIV and hepatitis C are at greater risk for myocardial infarction as they age, and traditional risk factors also matter.
The heart transplant recipient—a woman in her sixties—also received a new kidney during the surgery at a Bronx, New York, hospital.
The cyberattack did not involve ransomware or disrupt patient care, says Broward Health of southeast Florida.
A large analysis of Austrian people living with HIV suggests that high CD4 counts are no protection against heart disease.
An implantable synthetic tissue created in a lab may one day allow doctors to repair damaged hearts, muscles and vocal cords.
Advocate and blogger Bob Leahy shares how his life-changing heart surgery altered the course of his HIV advocacy.
Sometimes the older formulation of tenofovir is a better choice for HIV prevention.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.